New Prop Trading Firm Funded.Global Launches with Unique Features

Funded.Global has officially entered the prop trading industry, setting a new standard for what traders can expect from a prop trading firm. Born out of a genuine understanding of traders’ needs and challenges, Funded.Global stands as a testament to the principle of being created by traders for traders.

This prop trading firm prioritizes investment stability and user convenience, making it a standout choice for all traders. With its innovative approach and commitment to addressing the real challenges traders face, Funded.Global is not just another prop trading firm but a pioneer setting new precedents for flexibility, transparency, and trader empowerment.

A Prop Trading Firm Where Transparency Meets Innovation

Funded.Global has woven transparency into the fabric of its operations, ensuring that every decision and policy is clear and upfront – no fine print, no surprises. This commitment is prominent in their approach to challenge monitoring, where traders can easily view all metrics and goals through live-updated, interactive charts.

This level of openness is rare in the prop trading industry and positions Funded.Global as a true innovator, paving new paths with trading contests that include both – monthly contests and the exclusive annual Grand Trading Championship, setting a new standard for what traders can expect from a prop trading firm.

Challenge Customization & Unmatched Flexibility

Funded.Global understands that one size does not fit all in trading. That’s why the prop trading firmintroduces us to flexible challenge customization. This feature allows traders to select the account size that suits their interests and tailor the challenge according to their preferences.

Whether it’s increasing leverage for more freedom in trading or adjusting the profit target to ease the first stage of the challenge, Funded.Global offers unusual flexibility. This adaptability extends to their unlimited scaling plan, which intelligently scales traders’ accounts with each payout while adjusting the maximum permitted drawdown level, ensuring that traders have every opportunity to grow their earnings.

Dedicated Rewards for Exceptional Trading Achievements

Funded.Global, a pioneering prop trading firm, has established a dedicated rewards tab on its platform, where traders can find certificates of achievement awaiting them. This approach not only acknowledges the trader’s hard work and success but also encourages continuous improvement and engagement with the platform.

In addition to digital recognition, Funded.Global elevates the traditional reward system by offering a WelcomeBox filled with hand-picked gadgets. These tangible rewards are sent directly to the trader’s address, creating a more personal and memorable token of achievement.

Innovative Features and Benefits at Funded.Global

Funded.Global stands out in the prop trading industry by prioritizing trader comfort and efficiency in payouts. Offering a variety of payout options, including bank transfers and cryptocurrency, Funded.Global delivers seamless access to profits, demonstrating its commitment to providing an exceptional trading experience. This prop trading firm respects traders’ preferences and needs, making it a top choice for those looking for flexibility and ease in managing their earnings.

Additionally, Funded.Global distinguishes itself by eliminating the stress of time limits on trading challenges and accounts. This approach allows traders to operate without pressure, allowing them to focus on strategic decision-making and optimizing their trading strategies.

By creating a stable and supportive trading environment, Funded.Global underscores its innovative approach and dedication to trader success.

Discover the Future of Prop Trading with Funded.Global

As Funded.Global officially steps into the prop trading industry, it brings a fresh perspective focused on transparency, innovation, and trader empowerment. With its unique offerings, Funded.Global is ready to redefine what traders can expect from a prop trading firm. Join the revolution and discover a partner dedicated to your success in the ever-evolving world of prop trading.

Website | X | Discord | YouTube

Website: https://funded.global

Media Details:

Company Name: FXFG LTD.

Brand Name: Funded.Global

Contact Person: Neofytos Nefytou

Address: Evripidou 9A 3031 Limassol, Cyprus

Business Email: [email protected]

Website: https://funded.global

AGC Biologics to Manufacture First-ever FDA Approved Gene Therapy for Early-onset Metachromatic Leukodystrophy, Orchard Therapeutics Lenmeldy (atidarsagene autotemcel)

–News Direct–

AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), today announced that the U.S. Food and Drug Administration (FDA) has cleared its Milan site to begin commercial manufacturing for the lentiviral vector and genetically modified cell drug product (DP) of Orchard Therapeutics Lenmeldy (atidarsagene autotemcel), a hematopoietic stem cell (HSC) gene therapy for the treatment of pre-symptomatic late infantile, pre-symptomatic early juvenile and early symptomatic early juvenile metachromatic leukodystrophy (MLD). Lenmeldy received approval by the FDA on Monday, March 18.

It is wonderful to see Orchard Therapeutics reach this goal. This accomplishment is a strong proof point of our commitment at AGC Biologics to collaborating directly with developers to meet rigorous regulatory standards and achieve the best possible results for our partners, says Patricio Massera, CEO of AGC Biologics.

Lenmeldy is the first therapy to receive U.S. FDA approval for MLD. With this announcement, AGC Biologics Milan becomes the only global CDMO site to receive the regulatory agencys clearance to produce this treatment for patients in the U.S. commercially. The FDA approval is the culmination of a partnership that started in 2018 with Orchard Therapeutics, which also includes guiding the product through commercial approval by the European Commission (EC) in 2021. AGC Biologics Milan site is uniquely connected to this products full lifecycle, as the facility and its scientific teams partnered with each company that owned this treatments IP over the last 20 years to help advance it from research and development stages to this DP commercial milestone.

We congratulate Orchard for reaching this important stage. Our team has had the privilege of supplying every clinical milestone for Lenmeldy and are glad to see it reach FDA approval, said Luca Alberici, General Manager of AGC Biologics Milan. I am proud of the work of the Milan team. This demonstrates our unique ability to collaborate on technical processes to deliver groundbreaking treatments to patients worldwide. This approval makes our site one of the rare few in the viral vector and genetically modified cells field that has commercial manufacturing authorization from two of the worlds leading regulatory authorities."

"AGC Biologics has played a pivotal role as a strategic partner throughout the clinical development and commercial scale-up of atidarsagene autotemcel, which helped facilitate regulatory approvals in Europe and the U.S.," said Nicoletta Loggia, Ph.D., chief technical officer of Orchard Therapeutics. "Utilizing our best-in-class commercial HSC gene therapy manufacturing platform, we have consistently met the demands for drug product production since the European launch in early 2021. This has enabled us to provide treatment to patients from three continents, including Europe on a commercial basis, the Middle East through treatment abroad programs, and the U.S., under compassionate use. With the recent U.S. approval, we are excited to further expand access to this vital therapy for eligible children with early-onset MLD.

The AGC Biologics Milan location has 30 years of experience in the cell and gene field and expertise with complex advanced cell therapy projects. The core team has guided three cell therapy products from development to commercial stages and has manufactured hundreds of batches of cell therapies for clinical and commercial usage. The site serves as the AGC Biologics Global Cell and Gene Center of Excellence for AGC Biologics.

The team has a track record for helping developers meet regulatory guidelines and achieve quality performance metrics, and experience with navigating the unique complexities of technology transfers and scaling up and scaling out manufacturing within the cell and gene space.

To learn more about AGC Biologics global cell therapy services, visit: www.agcbio.com/capabilities/cell-therapy, go to www.agcbio.com/capabilities/viral-vector and learn more about the CDMOs viral vector offerings.

Lenmeldy (atidarsagene autotemcel) is a trademark of Orchard Therapeutics.

About AGC Biologics:

AGC Biologics is a leading global biopharmaceutical Contract Development and Manufacturing Organization (CDMO) with a strong commitment to delivering the highest standard of service as we work side-by-side with our clients and partners, every step of the way. We provide world-class development and manufacture of mammalian and microbial-based therapeutic proteins, plasmid DNA (pDNA), messenger RNA (mRNA), viral vectors, and genetically engineered cells. Our global network spans the U.S., Europe, and Asia, with cGMP-compliant facilities in Seattle, Washington; Boulder and Longmont, Colorado; Copenhagen, Denmark; Heidelberg, Germany; Milan, Italy; and Chiba, Japan. We currently employ more than 2,500 employees worldwide. Our commitment to continuous innovation fosters the technical creativity to solve our clients most complex challenges, including specialization in fast-track projects and rare diseases. AGC Biologics is a part of AGC Inc.s Life Science Company. The Life Science company runs ten different facilities focused on biopharmaceuticals, advanced therapies, small molecule active pharmaceutical ingredients, and agrochemicals. To learn more, visit www.agcbio.com.

Contact Details

AGC Biologics

Nick McDonald

+1 425-419-3555

[email protected]

Company Website

https://www.agcbio.com/

View source version on newsdirect.com: https://newsdirect.com/news/agc-biologics-to-manufacture-first-ever-fda-approved-gene-therapy-for-early-onset-metachromatic-leukodystrophy-orchard-therapeutics-lenmeldy-atidarsagene-autotemcel-406986738

AGC Biologics

comtex tracking

COMTEX_449478531/2655/2024-03-19T02:35:36

Unveiling the interzum guangzhou Award 2024 Winners!

Guangzhou, China – Highly anticipated within the Asian furniture industry, CIFM / interzum guangzhou 2024 is gearing up for its opening from March 28th to 31st at the Canton Fair Complex, Pazhou, Guangzhou. Renowned as a global hub for pioneering technologies and applications in the furniture production sector, this exhibition is poised to host over 1,300 leading enterprises from nearly 30 countries and regions.

C:UsersSHECHU~1AppDataLocalTempWeChat Files152b703420e3cd0fdc03d41a370d6c0.jpg

Step into the realm of innovation as we unveil the winners of the interzum guangzhou Award 2024 – the pinnacle of innovation in Asia’s furniture manufacturing industry! The “interzum guangzhou Exclusive” Awards celebrate the dedication of companies committed to delivering top-tier products and advancing the boundaries of research and development. Meanwhile, the “Outstanding Furniture Accessories” Awards spotlight exceptional products brimming with potential for further growth and development.

“interzum guangzhou Exclusive” Winners (Not in any particular order):

C:UsersSHECHU~1AppDataLocalTempWeChat Files46ddb99226fa612f4a969b2666b0e68.jpg

“Outstanding Furniture Accessories” Winners (Not in any particular order):

C:UsersSHECHU~1AppDataLocalTempWeChat Files50a348be5fb059e714ee89270060e0b.jpg

Amidst environmental concerns and the rise of the global digital economy, the furniture manufacturing industry faces new demands for eco-friendliness, reduced energy consumption, and innovative production processes. This year’s nominees for the interzum guangzhou Award showcase emerging trends in sustainable development, customization, innovation, and safety, marking a significant stride towards technological transformation in the furniture sector.

Renowned international designer Dick Spierenburg, a longstanding judge of the interzum guangzhou Award, remarks, “interzum guangzhou Award is showing the latest product and material innovations and support the industry to keep informed and motivated to deliver optimal performance. “

Joining the international advisory board for the first time this year, product design expert Kristina Meyer observes, “Based on the entries reviewed, the current trends and innovations in the furniture manufacturing industry are strongly focused on sustainability, technology integration, customization, and transparency.”

Derived from the esteemed interzum Award, a pinnacle in global furniture manufacturing accolades, the interzum guangzhou Award stands as a vital recognition platform within CIFM / interzum guangzhou. With its authority, professionalism, and high visibility, the award offers a robust endorsement for companies and guides the industry towards forward-thinking directions.

Sascha Peters, European material expert and ambassador for the Red Dot Design Award, who has served as a judge for three consecutive years, lauds, “With the interzum guangzhou Award, Koelnmesse has an ideal instrument to reflect innovation activities. It can also proactively accompany the transformation process towards a circular economy in a digital world and provide valuable information for producers across the entire industry.”

The mission of interzum guangzhou Award is to spotlight and celebrate innovative designs that resonate across Asia and beyond, offering vital material references for furniture designers and craftsmen. Join us from March 28 to 31 at the interzum guangzhou Award Showcase (Entrance of Hall 15.1, Area C, Pazhou Complex) to check out these innovative products firsthand!

Visitor pre-registration for interzum guangzhou is open. Please visit www.interzum-guangzhou.com for more information or to register.

Media Contact

Organization: Koelnmesse (Beijing) Co., Ltd. Guangzhou Branch

Contact Person: Elly Li (Senior Marketing Manager)

Website: http://www.koelnmesse.cn/

Email:[email protected]

Contact Number: +86 20 8755 2468

SX Bet Takes a Giant Leap in Sports Betting Innovation with Zero Fees and Cross-Chain Expansion

Toronto, Canada, 19th March 2024, ZEX PR WIRE, The SX Bet team is excited to announce it has taken a leap forward in its mission to revolutionize the sports betting industry by eliminating fees. The move to zero commission has SX Bet positioned to be the lowest vig sports betting platform and have the best odds in the world. In tandem with this groundbreaking change, SX Bet is also pioneering the industry as the first cross-chain gambling application, starting with an imminent launch on Arbitrum.

This dual advancement not only redefines the economics of sports betting but also expands SX Bet’s reach, welcoming a broader, crypto-native audience across multiple chains. 

Elimination of Commission Fees

In a landmark move, SX Bet has reduced commission rates to zero, meaning both makers and takers pay 0% commission on all bets, including parlay bets.”While exploring different monetization routes, SX has taken the step to cut commission rates to zero for the time being,” Andrew Young, Project Lead at SX explains, highlighting the platform’s commitment to reducing vig in sports betting to zero while also drastically increasing fairness.

On top of paying no commission, SX rewards bettors weekly in its native governance token $SX for using the platform. This means the net commission paid on bets is actually negative; SX bettors are effectively being paid to bet.

SX Bet Launching on Arbitrum 

The expansion onto Arbitrum on March 19th signifies SX Bet’s entry as the first cross-chain betting application, a strategic move designed to capture the vast, untapped crypto-native audience across multiple chains.

The Arbitrum launch is accompanied by a series of exciting incentives and promotions, including an Airdrop and a $69,420 betting tournament, all aimed at celebrating the milestone and encouraging widespread participation.

About SX 

SX Network blockchain combines smart contracts with an on-chain treasury and prediction market protocol. It offers low-cost transactions, and a PoS-based consensus, making it ideal for developers with EVM compatibility. SX Network’s flagship platform, SX Bet, is the largest blockchain betting platform in the world, having processed over $437,000,000 in betting volume. The platform is non-custodial, all bets are peer-to-peer and settled transparently on-chain. SX Bet is not available in the United States or other prohibited jurisdictions.

X (Twitter) | Discord | YouTube

New Prop Trading Firm Funded.Global Launches with Unique Features

Funded.Global has officially entered the prop trading industry, setting a new standard for what traders can expect from a prop trading firm. Born out of a genuine understanding of traders’ needs and challenges, Funded.Global stands as a testament to the principle of being created by traders for traders.

This prop trading firm prioritizes investment stability and user convenience, making it a standout choice for all traders. With its innovative approach and commitment to addressing the real challenges traders face, Funded.Global is not just another prop trading firm but a pioneer setting new precedents for flexibility, transparency, and trader empowerment.

A Prop Trading Firm Where Transparency Meets Innovation

Funded.Global has woven transparency into the fabric of its operations, ensuring that every decision and policy is clear and upfront – no fine print, no surprises. This commitment is prominent in their approach to challenge monitoring, where traders can easily view all metrics and goals through live-updated, interactive charts.

This level of openness is rare in the prop trading industry and positions Funded.Global as a true innovator, paving new paths with trading contests that include both – monthly contests and the exclusive annual Grand Trading Championship, setting a new standard for what traders can expect from a prop trading firm.

Challenge Customization & Unmatched Flexibility

Funded.Global understands that one size does not fit all in trading. That’s why the prop trading firmintroduces us to flexible challenge customization. This feature allows traders to select the account size that suits their interests and tailor the challenge according to their preferences.

Whether it’s increasing leverage for more freedom in trading or adjusting the profit target to ease the first stage of the challenge, Funded.Global offers unusual flexibility. This adaptability extends to their unlimited scaling plan, which intelligently scales traders’ accounts with each payout while adjusting the maximum permitted drawdown level, ensuring that traders have every opportunity to grow their earnings.

Dedicated Rewards for Exceptional Trading Achievements

Funded.Global, a pioneering prop trading firm, has established a dedicated rewards tab on its platform, where traders can find certificates of achievement awaiting them. This approach not only acknowledges the trader’s hard work and success but also encourages continuous improvement and engagement with the platform.

In addition to digital recognition, Funded.Global elevates the traditional reward system by offering a WelcomeBox filled with hand-picked gadgets. These tangible rewards are sent directly to the trader’s address, creating a more personal and memorable token of achievement.

Innovative Features and Benefits at Funded.Global

Funded.Global stands out in the prop trading industry by prioritizing trader comfort and efficiency in payouts. Offering a variety of payout options, including bank transfers and cryptocurrency, Funded.Global delivers seamless access to profits, demonstrating its commitment to providing an exceptional trading experience. This prop trading firm respects traders’ preferences and needs, making it a top choice for those looking for flexibility and ease in managing their earnings.

Additionally, Funded.Global distinguishes itself by eliminating the stress of time limits on trading challenges and accounts. This approach allows traders to operate without pressure, allowing them to focus on strategic decision-making and optimizing their trading strategies.

By creating a stable and supportive trading environment, Funded.Global underscores its innovative approach and dedication to trader success.

Discover the Future of Prop Trading with Funded.Global

As Funded.Global officially steps into the prop trading industry, it brings a fresh perspective focused on transparency, innovation, and trader empowerment. With its unique offerings, Funded.Global is ready to redefine what traders can expect from a prop trading firm. Join the revolution and discover a partner dedicated to your success in the ever-evolving world of prop trading.

Website | X | Discord | YouTube

Website: https://funded.global

Media Details:

Company Name: FXFG LTD.

Brand Name: Funded.Global

Contact Person: Neofytos Nefytou

Address: Evripidou 9A 3031 Limassol, Cyprus

Business Email: [email protected]

Website: https://funded.global

AGC Biologics to Manufacture First-ever FDA Approved Gene Therapy for Early-onset Metachromatic Leukodystrophy, Orchard Therapeutics Lenmeldy (atidarsagene autotemcel)

–News Direct–

AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), today announced that the U.S. Food and Drug Administration (FDA) has cleared its Milan site to begin commercial manufacturing for the lentiviral vector and genetically modified cell drug product (DP) of Orchard Therapeutics Lenmeldy (atidarsagene autotemcel), a hematopoietic stem cell (HSC) gene therapy for the treatment of pre-symptomatic late infantile, pre-symptomatic early juvenile and early symptomatic early juvenile metachromatic leukodystrophy (MLD). Lenmeldy received approval by the FDA on Monday, March 18.

It is wonderful to see Orchard Therapeutics reach this goal. This accomplishment is a strong proof point of our commitment at AGC Biologics to collaborating directly with developers to meet rigorous regulatory standards and achieve the best possible results for our partners, says Patricio Massera, CEO of AGC Biologics.

Lenmeldy is the first therapy to receive U.S. FDA approval for MLD. With this announcement, AGC Biologics Milan becomes the only global CDMO site to receive the regulatory agencys clearance to produce this treatment for patients in the U.S. commercially. The FDA approval is the culmination of a partnership that started in 2018 with Orchard Therapeutics, which also includes guiding the product through commercial approval by the European Commission (EC) in 2021. AGC Biologics Milan site is uniquely connected to this products full lifecycle, as the facility and its scientific teams partnered with each company that owned this treatments IP over the last 20 years to help advance it from research and development stages to this DP commercial milestone.

We congratulate Orchard for reaching this important stage. Our team has had the privilege of supplying every clinical milestone for Lenmeldy and are glad to see it reach FDA approval, said Luca Alberici, General Manager of AGC Biologics Milan. I am proud of the work of the Milan team. This demonstrates our unique ability to collaborate on technical processes to deliver groundbreaking treatments to patients worldwide. This approval makes our site one of the rare few in the viral vector and genetically modified cells field that has commercial manufacturing authorization from two of the worlds leading regulatory authorities."

"AGC Biologics has played a pivotal role as a strategic partner throughout the clinical development and commercial scale-up of atidarsagene autotemcel, which helped facilitate regulatory approvals in Europe and the U.S.," said Nicoletta Loggia, Ph.D., chief technical officer of Orchard Therapeutics. "Utilizing our best-in-class commercial HSC gene therapy manufacturing platform, we have consistently met the demands for drug product production since the European launch in early 2021. This has enabled us to provide treatment to patients from three continents, including Europe on a commercial basis, the Middle East through treatment abroad programs, and the U.S., under compassionate use. With the recent U.S. approval, we are excited to further expand access to this vital therapy for eligible children with early-onset MLD.

The AGC Biologics Milan location has 30 years of experience in the cell and gene field and expertise with complex advanced cell therapy projects. The core team has guided three cell therapy products from development to commercial stages and has manufactured hundreds of batches of cell therapies for clinical and commercial usage. The site serves as the AGC Biologics Global Cell and Gene Center of Excellence for AGC Biologics.

The team has a track record for helping developers meet regulatory guidelines and achieve quality performance metrics, and experience with navigating the unique complexities of technology transfers and scaling up and scaling out manufacturing within the cell and gene space.

To learn more about AGC Biologics global cell therapy services, visit: www.agcbio.com/capabilities/cell-therapy, go to www.agcbio.com/capabilities/viral-vector and learn more about the CDMOs viral vector offerings.

Lenmeldy (atidarsagene autotemcel) is a trademark of Orchard Therapeutics.

About AGC Biologics:

AGC Biologics is a leading global biopharmaceutical Contract Development and Manufacturing Organization (CDMO) with a strong commitment to delivering the highest standard of service as we work side-by-side with our clients and partners, every step of the way. We provide world-class development and manufacture of mammalian and microbial-based therapeutic proteins, plasmid DNA (pDNA), messenger RNA (mRNA), viral vectors, and genetically engineered cells. Our global network spans the U.S., Europe, and Asia, with cGMP-compliant facilities in Seattle, Washington; Boulder and Longmont, Colorado; Copenhagen, Denmark; Heidelberg, Germany; Milan, Italy; and Chiba, Japan. We currently employ more than 2,500 employees worldwide. Our commitment to continuous innovation fosters the technical creativity to solve our clients most complex challenges, including specialization in fast-track projects and rare diseases. AGC Biologics is a part of AGC Inc.s Life Science Company. The Life Science company runs ten different facilities focused on biopharmaceuticals, advanced therapies, small molecule active pharmaceutical ingredients, and agrochemicals. To learn more, visit www.agcbio.com.

Contact Details

AGC Biologics

Nick McDonald

+1 425-419-3555

[email protected]

Company Website

https://www.agcbio.com/

View source version on newsdirect.com: https://newsdirect.com/news/agc-biologics-to-manufacture-first-ever-fda-approved-gene-therapy-for-early-onset-metachromatic-leukodystrophy-orchard-therapeutics-lenmeldy-atidarsagene-autotemcel-406986738

AGC Biologics

comtex tracking

COMTEX_449478531/2655/2024-03-19T02:35:36

Unveiling the interzum guangzhou Award 2024 Winners!

Guangzhou, China – Highly anticipated within the Asian furniture industry, CIFM / interzum guangzhou 2024 is gearing up for its opening from March 28th to 31st at the Canton Fair Complex, Pazhou, Guangzhou. Renowned as a global hub for pioneering technologies and applications in the furniture production sector, this exhibition is poised to host over 1,300 leading enterprises from nearly 30 countries and regions.

C:UsersSHECHU~1AppDataLocalTempWeChat Files152b703420e3cd0fdc03d41a370d6c0.jpg

Step into the realm of innovation as we unveil the winners of the interzum guangzhou Award 2024 – the pinnacle of innovation in Asia’s furniture manufacturing industry! The “interzum guangzhou Exclusive” Awards celebrate the dedication of companies committed to delivering top-tier products and advancing the boundaries of research and development. Meanwhile, the “Outstanding Furniture Accessories” Awards spotlight exceptional products brimming with potential for further growth and development.

“interzum guangzhou Exclusive” Winners (Not in any particular order):

C:UsersSHECHU~1AppDataLocalTempWeChat Files46ddb99226fa612f4a969b2666b0e68.jpg

“Outstanding Furniture Accessories” Winners (Not in any particular order):

C:UsersSHECHU~1AppDataLocalTempWeChat Files50a348be5fb059e714ee89270060e0b.jpg

Amidst environmental concerns and the rise of the global digital economy, the furniture manufacturing industry faces new demands for eco-friendliness, reduced energy consumption, and innovative production processes. This year’s nominees for the interzum guangzhou Award showcase emerging trends in sustainable development, customization, innovation, and safety, marking a significant stride towards technological transformation in the furniture sector.

Renowned international designer Dick Spierenburg, a longstanding judge of the interzum guangzhou Award, remarks, “interzum guangzhou Award is showing the latest product and material innovations and support the industry to keep informed and motivated to deliver optimal performance. “

Joining the international advisory board for the first time this year, product design expert Kristina Meyer observes, “Based on the entries reviewed, the current trends and innovations in the furniture manufacturing industry are strongly focused on sustainability, technology integration, customization, and transparency.”

Derived from the esteemed interzum Award, a pinnacle in global furniture manufacturing accolades, the interzum guangzhou Award stands as a vital recognition platform within CIFM / interzum guangzhou. With its authority, professionalism, and high visibility, the award offers a robust endorsement for companies and guides the industry towards forward-thinking directions.

Sascha Peters, European material expert and ambassador for the Red Dot Design Award, who has served as a judge for three consecutive years, lauds, “With the interzum guangzhou Award, Koelnmesse has an ideal instrument to reflect innovation activities. It can also proactively accompany the transformation process towards a circular economy in a digital world and provide valuable information for producers across the entire industry.”

The mission of interzum guangzhou Award is to spotlight and celebrate innovative designs that resonate across Asia and beyond, offering vital material references for furniture designers and craftsmen. Join us from March 28 to 31 at the interzum guangzhou Award Showcase (Entrance of Hall 15.1, Area C, Pazhou Complex) to check out these innovative products firsthand!

Visitor pre-registration for interzum guangzhou is open. Please visit www.interzum-guangzhou.com for more information or to register.

Media Contact

Organization: Koelnmesse (Beijing) Co., Ltd. Guangzhou Branch

Contact Person: Elly Li (Senior Marketing Manager)

Website: http://www.koelnmesse.cn/

Email:[email protected]

Contact Number: +86 20 8755 2468

SX Bet Takes a Giant Leap in Sports Betting Innovation with Zero Fees and Cross-Chain Expansion

Toronto, Canada, 19th March 2024, ZEX PR WIRE, The SX Bet team is excited to announce it has taken a leap forward in its mission to revolutionize the sports betting industry by eliminating fees. The move to zero commission has SX Bet positioned to be the lowest vig sports betting platform and have the best odds in the world. In tandem with this groundbreaking change, SX Bet is also pioneering the industry as the first cross-chain gambling application, starting with an imminent launch on Arbitrum.

This dual advancement not only redefines the economics of sports betting but also expands SX Bet’s reach, welcoming a broader, crypto-native audience across multiple chains. 

Elimination of Commission Fees

In a landmark move, SX Bet has reduced commission rates to zero, meaning both makers and takers pay 0% commission on all bets, including parlay bets.”While exploring different monetization routes, SX has taken the step to cut commission rates to zero for the time being,” Andrew Young, Project Lead at SX explains, highlighting the platform’s commitment to reducing vig in sports betting to zero while also drastically increasing fairness.

On top of paying no commission, SX rewards bettors weekly in its native governance token $SX for using the platform. This means the net commission paid on bets is actually negative; SX bettors are effectively being paid to bet.

SX Bet Launching on Arbitrum 

The expansion onto Arbitrum on March 19th signifies SX Bet’s entry as the first cross-chain betting application, a strategic move designed to capture the vast, untapped crypto-native audience across multiple chains.

The Arbitrum launch is accompanied by a series of exciting incentives and promotions, including an Airdrop and a $69,420 betting tournament, all aimed at celebrating the milestone and encouraging widespread participation.

About SX 

SX Network blockchain combines smart contracts with an on-chain treasury and prediction market protocol. It offers low-cost transactions, and a PoS-based consensus, making it ideal for developers with EVM compatibility. SX Network’s flagship platform, SX Bet, is the largest blockchain betting platform in the world, having processed over $437,000,000 in betting volume. The platform is non-custodial, all bets are peer-to-peer and settled transparently on-chain. SX Bet is not available in the United States or other prohibited jurisdictions.

X (Twitter) | Discord | YouTube

Book of Meme (BOME) Alert: New Challenger Token Launches This Friday

Exciting news for Book of Meme (BOME) fans! A new challenger token is set to launch this Friday. Get ready to add this new token to your crypto collection!

Book of Meme Poised for 436% Growth, Exceeding $1 Billion Market Cap

BOME coin has taken the crypto world by storm, rocketing to a billion-dollar market cap in a mere 48 hours post-launch and offering an astounding 40x return on investment to those who got in early.

As these initial investors weigh the option of cashing in on their gains, those who didn’t catch the wave initially are now wondering if it’s their time to dive in. If you find yourself in this second group, worry not.

This article will shed light on the price predictions for BOME, covering both immediate and future projections. However, BOME isn’t the only contender catching the eye of investors.

 Pikamoon (PIKA) is a rising star set to debut on various cryptocurrency exchanges come Friday, March 22nd. PIKA stands at the brink of potentially offering transformative returns for its investors. Join us as we dive deep into the forecasts for BOME and explore the bright future awaiting Pikamoon.

History of Book of Meme, BOME

The Book of Meme, launched by DarkFarms, the brains behind the widely known memecoin Pepecoin stands as an innovative venture. BOME is pioneering an experimental space where

memes, decentralized storage, speculative altcoin trading, and gambling converge, crafting a unique web3 experience.

In the span of just two days, the Book of Meme witnessed a meteoric rise, soaring to a price of $0.012 and securing a market capitalization of $1 billion. The fastest token to ever hit a $1 billion market cap.

Is PIKA better Than Other MEME Coins?

Tokens like BOME, BONK, WIF, and PEPE soar with a mix of admiration and a hint of jealousy, you’re definitely not alone. However, don’t lose hope yet; the upcoming Pikamoon (PIKA) launch could be your chance to get in on the ground floor of the next big crypto success.

Traders who reaped rewards from early bets on next top Meme coins BONK, BOME, or PEPE were just early birds catching the worm. Launching at an enticing price of $0.0007 and a market cap of $10 million, PIKA offers a golden opportunity to invest early and possibly enjoy returns ranging from 100x to 400x as the token enters the market.

While the buzz around memecoins is undeniable, smart investors look for projects with genuine utility to ensure lasting value. Pikamoon emerges as such a project, blending the appeal of memecoins with the practicality of GameFi. Boasting a transparent, fully doxed team, a strong base of over 15,000 holders, and more than 7,500 beta players, Pikamoon is a shining example of innovation and community in the cryptocurrency world.

PIKA Launch on Top CEXs

 What really distinguishes Pikamoon is its bold aim to create a vast, open-world metaverse, spearheaded by its dedicated in-house game development team. Drawing inspiration from renowned titles like Axie Infinity, Pikamoon is set to offer both players and investors exceptional gaming experiences coupled with significant earning possibilities.

As we stand on the cusp of what could be the crypto market’s most significant bull run, with Bitcoin hitting peaks over $69,000 and the overall market value crossing the $3 trillion mark, Pikamoon positions itself as a prime candidate for remarkable growth.

 

This is a golden opportunity to become an early investor in Pikamoon. Given its modest market capitalization and extraordinary growth potential, securing PIKA now might just be your gateway to unparalleled crypto wealth.

Make sure to visit the Pikamoon website for direct links to their social media channels. Platforms like X, Telegram and Reddit are your go-to for the latest updates on PIKA’s upcoming launches on major centralized exchanges (CEXs) on March 22.

PIKA Price Prediction

By 2025, market trends, strong community backing, and the rapid expansion of the GameFi industry suggest a significant uptick in PIKA’s value, with an expected average price of $1.50. This forecast underlines the growing appetite for cutting-edge gaming ventures that blend meme coin appeal with Play-to-Earn mechanics.

As the gaming sector further integrates blockchain innovations, PIKA’s distinct offering is poised to attract keen interest from both investors and gaming enthusiasts.

 

Read the full article on Coinpaper.com

 

AZTEQ Metaverse Evolves “Life” – GameFi Unlocked for Everyone

Netherlands, Rosmalen — World’s First Web3 Native Metaverse Platform Revolutionizes Digital Interaction

In an era where the digital world is rapidly evolving, one particular platform has emerged as a game-changer in the realm of GameFi. This platform, the world’s first web3 native metaverse, is redefining the boundaries of digital interaction with its innovative tech partnerships, exciting new IP collaborations, and advanced security and privacy measures. It is an ultra high-capacity metaverse boldly named, “Life”. Under the stewardship of a project called AZTEQ Metaverse, the evolution of Life has been high-velocity and shows no signs of slowing down.

Innovative Tech Expansion

The strategy for growth seems to be go big or go home. Last year the project took on collaborations with major brands including Lenovo, Disney, NVIDIA, SafeSwap and Nike SWOOSH. The push for technological innovation comes with an announcement to provide staking capabilities via partner SafeSwap. The roadmap involves staking for both tokens and NFTs in combination. This will allow owners of playable items and purchased land to stake assets in an integrated and player friendly way. Another gaming innovator to join the fold is Millburn Pennybags, bringing a well loved figure from the Hasbro game Monopoly, into the AZTEQ Metaverse. With an in-world venue providing the ability to buy tickets and win prizes based on blockchain technology with jackpot bots and smart contracts to govern transactions. The player model leverages the lottery system, where the more players there are, the bigger the prizes. The team at AZTEQ Metaverse is also in talks with a trailblazing decentralised finance provider that is empowering players to launch their own tokens with ease. The crossover between day-trader and night-gamer continues.

Exciting New IP Partnerships

In addition to its expanding tech footprint, the platform has also entered into strategic alliances with several intellectual property (IP) holders. These collaborations have resulted in expanded access to familiar brands and fandoms of pop-culture assets. The trend continues this year with Hasbro agreeing to open up the Transformers property, Nintendo granting access to the Pokemon property and fashion and beauty icons Amiri, Maybelline and MAC Cosmetics all striking up key alliances in the first quarter alone. The brace of companies already well versed and familiar with branding, user journeys and engagement in the metaverse paradigm is growing. Combining the commercial and social media aspects of a web3 native metaverse seems to be appealing to a variety of established and well-known global brands. Another franchise making an appearance in the AZTEQ Metaverse stable is The Mandolorian. The much lauded hit show from Disney and Star Wars, is working with the design and engineering teams over at the pioneering metaverse. In another move to power-up the Visual Development program, AZTEQ Metaverse has newly partnered up with ArtKing Studio, an awarded and deeply experienced collective of graphical geniuses based in the Netherlands. They aim to bring high-end 3D art from a galaxy, far, far away, much closer to home. 

Early results were already showcased in February this year, demonstrating the ability to apply custom skins from the TV franchise and add them to 3D playable models based on avatars from players own NFT collections. These currently include Nakamigos, Wonkey Donkey, BAYC, MFers, and Disney Pinnacle.  If you happen to have Pepe, Floki and Shib Inu in your virtual asset explorer you can morph into those avatars too! The options are wide-ranging and another industry first.

Advanced Security and Privacy Measures

Security and privacy are paramount in the digital world, and this platform has taken extensive measures to ensure that users can explore the metaverse with peace of mind. The platform utilizes state-of-the-art encryption technologies to protect user data, and its privacy policies are designed to give users control over their assets and information. These collaborations have resulted in unique features such as seamless integration with various blockchain networks, enabling users to interact with digital assets in a more immersive and intuitive way. The nexus of interconnectivity, security and privacy comes to the fore with a new alliance with BlockBlend.io. BlockBlend is a suite of crypto privacy services aimed at retail crypto users that provides them the tools to secure their on-chain privacy. AZTEQ Metaverse already enables users to play, earn and spend inside the same ecosystem via it’s AZTEQ coin. They now have an option to spend that AZTEQ coin as they would spend FIAT currency, on a virtual VISA/Mastercard transaction in the real world. They say that crypto never sleeps and neither does the need for vigilance in the cybersecurity arena. Work continues on all fronts for optimising player security options. Recently, the AZTEQ smart contract has been passed by security audit firm Audit.SC with flying colours.

The world’s first web3 native metaverse platform is not just a gaming platform; it’s a revolutionary digital ecosystem that’s transforming the way we can interact with the digital world. With its innovative approach to immersion, experience and security,the platform is setting the standard for what the metaverse can and should be. 

Check out to the AZTEQ Metaverse team through the X platform and join our communities on Discord & Telegram for questions and news.

Disclaimer: This press release is for informational purposes only and does not constitute an offer or solicitation of an offer to buy or sell any securities or engage in any investment activity. Please consult legal and financial professionals for investment-related advice.

Company details
Media contact name: Zaf Khan
Email: [email protected]
Company: AZTEQ Metaverse